TECH
Bio-Techne Corporation
NASDAQ · Healthcare · Biotechnology · US
$72.43
−0.03%Forward multiples
Based on analyst estimates
- P/E forward
- 35.29x
- P/E 2026E
- —
- P/E 2027E
- 35.24x
- P/E 2028E
- 30.95x
- P/S forward
- 9.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- 61.91x
- PEG TTM
- 0.82x
- Price / book
- 5.39x
- Price / sales
- 9.35x
- Price / cash flow
- 38.89x
Enterprise value
- Enterprise value
- $11.4B
- EV / sales
- 9.37x
- EV / EBITDA
- 33.14x
- EV / EBIT
- 45.19x
- Market cap
- $11.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026